News items Young people with colorectal cancer deserve their own treatment
27 July 2021

Dutch people under the age of 25 with colon cancer form a small group within colon cancer patients (0.1% of the total number of colon cancer patients). Genetic studies of these patients and their tumors show that they are a unique group. Richarda de Voer, Marjolijn Ligtenberg, theme Tumours of the digestive tract, and colleagues published an article in Clinical Gastroenterology and Hepatology and argue that this group should be treated independently.

The study, funded by the Gastrointestinal Society (MLDS), began in 2013 by collecting data on - eventually - all 139 cases of colorectal cancer among young adults under 25 in the Netherlands between 2000-2017. Richarda de Voer and Marjolijn Ligtenberg, screened all of these people for this rare condition.

Often a genetic predisposition

By analyzing the DNA of the patients, a "genetic predisposition" was found in 39 percent of the cases. This means that the patients have an inherited predisposition to the development of the cancer. This percentage is much higher than usual, as it is less than five percent. Researcher Dr. De Voer: "It is important to know whether there is a genetic predisposition, because with predisposition there is often a chance of recurrence. Through regular checks we can detect a recurring or new colon cancer earlier. In addition, family members can also be tested. If it turns out that they are at increased risk, we can follow them."

Looking for the best treatment

Because tumors contain genetic mutations that do not occur in other body cells, the researchers also examined the genetic material of the patients' tumors. This showed that tumor-specific mutations also occur in different proportions among this subgroup than in older patients with colon cancer. Some of these changes may affect the patient's treatment. Marjolijn Ligtenberg: "We expect that a significant proportion of these young patients may benefit from immunotherapy. We therefore advocate genetic research in young patients with colorectal cancer, so that the best treatment can be found for them."

read more

More information

Pauline Dekhuijzen

wetenschaps- en persvoorlichter

neem contact op

Related news items

TropIQ seeks new mosquito repellents

21 September 2021

TropIQ Health Sciences, a Radboudumc spin-off, has received a 1.3 million USD grant from the Bill & Melinda Gates Foundation to track down new mosquito repellents.

read more

New start-up Patholyt will bring AI research into pathology diagnostics

21 September 2021

Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.

read more

Treatment of most common skin cancer can sometimes wait

20 September 2021

Not treating but keeping an eye on the cancer is also an option

read more

Donor limbs last longer thanks to improved preservation technology

17 September 2021

Research by Anne Sophie supported Maartje's double hand transplantation

read more

Young Radboudumc researchers receive grant to engage in bio-medical and health research that is off the beaten path

16 September 2021

The ZonMw Off Road program is once again giving young scientists the opportunity to conduct innovative research in medical and/or health care. This research is off the beaten track and aims to bring about new insights and unexpected breakthroughs for healthcare and healthcare innovation.

read more

Infections increase risk to develop dementia

16 September 2021

In a recently published study, Radboudumc researchers investigated the effects of infectious events on cognitive decline and the development of dementia and its possible structural underpinning using pre- and post-infection MRI of the brain.

read more